tm logo
SCA
Live/Pending
PUBLICATION/ISSUE REVIEW COMPLETE

on 18 Apr 2024

Last Applicant/ Owned by

Serial Number

98004249 filed on 19th May 2023

Registration Number

N/A

Correspondent Address

Marek KrizkaSPARRING LEGAL LLP

477 MAISSON AVENUE, 6TH LOOR

NEW YORK,NY

10022

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

SCA

Research and development in the field of oligonucleotide drug delivery platforms for use in the treatment of genetic diseases and disorders; research and development in the field of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of genetic diseases and disorders; and research and development in the field of oligonucleotide compounds for targeted gene silenRead More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Research and development in the field of oligonucleotide drug delivery platforms for use in the treatment of genetic diseases and disorders; research and development in the field of oligonucleotide compounds for use in targeted pharmaceutical therapies for the treatment of genetic diseases and disorders; and research and development in the field of oligonucleotide compounds for targeted gene silencing.

Mark Details


Serial Number

No 98004249

Mark Type

No Service Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
01st May 2024NOTIICATION O NOTICE O PUBLICATION E-MAILE
18th Apr 2024APPROVE OR PUB - PRINCIPAL REGISTER
17th Apr 2024TEAS REQUEST OR RECONSIERATION RECEIVE
17th Apr 2024TEAS/EMAIL CORRESPONENCE ENTERE
17th Apr 2024CORRESPONENCE RECEIVE IN LAW OICE
02th Apr 2024NOTIICATION O INAL REUSAL EMAILE
02th Apr 2024INAL REUSAL E-MAILE
02th Apr 2024INAL REUSAL WRITTEN
28th Feb 2024TEAS RESPONSE TO OICE ACTION RECEIVE
28th Feb 2024TEAS/EMAIL CORRESPONENCE ENTERE